Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1, 3- thiazolidin-5-ylacetic acid derivatives

Acta Poloniae Pharmaceutica - Drug Research

Volumn 66, Issue 1, 2009, Pages 51-56

  Imran, Mohammad ^a   Yar, Mohammad Shahar ^a   Khan, Suroor Ahmad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Antihyperglycemic activity; Thiazolidinones

Indexed keywords

[2 (2 HYDROXY 4 BROMOPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (2 HYDROXY 4 CHLOROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (2,4 DICHLOROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (2,6 DICHLOROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (3 CHLOROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (3 FLUOROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (4 CHLOROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (4 DIMETHYLAMINOPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (4 METHOXYPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; [2 (4 NITROPHENYL) 3 [[4 (1 NAPHTHYL) 1,3 THIAZOL 2 YL]AMINO] 4 OXO 1,3 THIAZOLIDIN 5 YL]ACETIC ACID; ALLOXAN; GLUCOSE; PIOGLITAZONE; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; SUCROSE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; INFRARED RADIATION; MALE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ANIMAL; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; INFRARED SPECTROPHOTOMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; WISTAR RAT;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; SUCROSE; THIAZOLIDINEDIONES;

EID: 62649162444     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Zimmet P.Z., Alberti K.G.M.M., Shaw J.: Nature 414, 782 (2001).
2. Seltzer H.S.: Endocrinol. Metab. Clin. North Am. 18, 163 (1989).
3. OíMoore-Sullivan T.M., Prins J.B.: Med. J. Aust. 176, 381 (2002).
4. Jacob N., Kutty G.N.: Indian Drugs 41, 76 (2004).
5. Joy J.M., Jacob N., Kutty G.N.: Indian Drugs 42, 47 (2005).
6. Madhavan G.R., Chakrabarti R., Vikramadithyan R.K., et al.: Bioorg. Med. Chem. 10, 2671 (2002).
7. Diamant M., Heine R.J.: Drugs 63, 1373 (2003).
8. Rao L., Mukerjee A.K.: Indian J. Chem. 33, 166 (1994).
9. Srimanth K., Rao V.R.: Indian J. Chem. 38, 473 (1999).
10. Rao V.R., Ravinder P., Rao T.V.P.: Indian J. Chem. 33, 579 (1994).
11. Goel A., Agarwal N., Singh F.V., et al.: Bioorg. Med. Chem. Lett. 14, 1089 (2004) .
12. Rao B.K., Sudarshan P.R., Rajasekhar M.D., Nagaraju N., Rao C.A.: J. Ethnopharmacol. 85, 169 (2003).
13. nd ed., pp 1017- 1019, Springer, Germany 2003.